Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
16.91
+3.38 (24.98%)
At close: Aug 13, 2025, 4:00 PM
16.57
-0.34 (-2.01%)
Pre-market: Aug 14, 2025, 9:00 AM EDT
Stoke Therapeutics Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Stoke Therapeutics stock ranges from a low of $22 to a high of $35. The average analyst price target of $26.6 forecasts a 57.30% increase in the stock price over the next year.
Price Target: $26.60 (+57.30%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Stoke Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 3 | 3 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 1 | 2 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +41.93% | Aug 13, 2025 |
| Wedbush | Wedbush | Buy Maintains $16 → $22 | Buy | Maintains | $16 → $22 | +30.10% | Aug 13, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +77.41% | Jul 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +30.10% | Jul 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $35 | Strong Buy | Maintains | $47 → $35 | +106.98% | May 14, 2025 |
Financial Forecast
Revenue This Year
186.11M
from 36.56M
Increased by 409.12%
Revenue Next Year
29.99M
from 186.11M
Decreased by -83.89%
EPS This Year
0.06
from -1.65
EPS Next Year
-2.83
from 0.06
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 223.7M | 73.5M | 110.3M | ||
| Avg | 186.1M | 30.0M | 48.2M | ||
| Low | 159.8M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 511.8% | -60.5% | 267.6% | ||
| Avg | 409.1% | -83.9% | 60.7% | ||
| Low | 337.2% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.89 | -1.73 | -0.60 | ||
| Avg | 0.06 | -2.83 | -2.28 | ||
| Low | -1.27 | -3.48 | -3.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.